cannabis pain medication manufacturer

A SPIEGEL investigation reports irregularities in the approval of a cannabis-based pain medication in Germany, raising questions about whether the government concealed contacts with the drug's manufacturer. New findings point to lobbying efforts by the producer, while the Federal Health Ministry has so far not given satisfactory answers about the nature of its dealings with the company.